GROUP ONE TRADING, L.P. - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 66 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$15,300
-15.1%
16,5410.0%0.00%
Q1 2023$18,030
-35.1%
16,541
-13.1%
0.00%
Q4 2022$27,787
+20.8%
19,032
-9.5%
0.00%
Q3 2022$23,000
-28.1%
21,032
+10.5%
0.00%
Q2 2022$32,000
-30.4%
19,032
-14.4%
0.00%
Q1 2022$46,000
-43.9%
22,232
+1.5%
0.00%
Q4 2021$82,000
+134.3%
21,906
+223.4%
0.00%
Q3 2021$35,000
-84.1%
6,774
-86.9%
0.00%
Q2 2021$220,000
+158.8%
51,729
+222.2%
0.00%
Q1 2021$85,000
+2733.3%
16,057
+3150.4%
0.00%
Q4 2020$3,000
-40.0%
494
-19.7%
0.00%
Q3 2020$5,000
-98.3%
615
-97.9%
0.00%
-100.0%
Q2 2020$287,000
+889.7%
28,621
+330.8%
0.00%
Q1 2019$29,000
-74.1%
6,643
-66.0%
0.00%
-100.0%
Q4 2018$112,000
-17.0%
19,525
+95.7%
0.00%0.0%
Q3 2018$135,000
+309.1%
9,978
+261.7%
0.00%
Q2 2018$33,000
+3200.0%
2,759
+1279.5%
0.00%
Q4 2017$1,000
-50.0%
2000.0%0.00%
Q3 2017$2,000
-88.9%
200
-92.0%
0.00%
Q3 2016$18,0002,5000.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 6,287,101$4,903,9392.63%
Syncona Portfolio Ltd 1,377,294$1,074,2891.60%
MPM BioImpact LLC 5,095,912$3,974,8111.06%
NEA Management Company, LLC 17,079,778$13,322,2271.03%
TANG CAPITAL MANAGEMENT LLC 5,166,954$4,030,2240.57%
PFM Health Sciences, LP 10,423,135$8,130,0450.38%
Matrix Capital Management Company, LP 38,974,185$30,399,8640.36%
Long Focus Capital Management, LLC 10,963,158$8,551,2630.31%
Acuitas Investments, LLC 479,764$374,2160.22%
Endurant Capital Management LP 311,944$243,3160.22%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders